ATR and cancer: As such, ever since Ataxia Telangiectasia Mutated and Rad3-related protein (ATR) was discovered to be a crucial component in the DDR pathway, developing strategies to target ATR have gained significant popularity as a cancer therapy [13,14,15,16].